A notable advancement in diabetes management is emerging with the release of tirzepatide at a dosage of 45mg. This updated formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://freshbookmarking.com/story21371275/revolutionary-approach-tirzepatide-dose-for-diabetes-management